Genes, geography and geometry: the "critical mass" in hypertrophic cardiomyopathy.
Kaludercic
Nina
N
Division of Cardiology, Department of Medicine, The Johns Hopkins Medical Institutions, Baltimore, Maryland.
Reggiani
Carlo
C
Department of Human Anatomy and Physiology, University of Padova, Padova, Italy.
Paolocci
Nazareno
N
Division of Cardiology, Department of Medicine, The Johns Hopkins Medical Institutions, Baltimore, Maryland; Department of Clinical Medicine, Section of General Pathology, University of Perugia, Perugia, Italy. Electronic address: npaoloc1@jhmi.edu.
D000804:Angiotensin II / Q000235:genetics / Q000378:metabolism; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D002312:Cardiomyopathy, Hypertrophic / Q000188:drug therapy / Q000453:epidemiology / Q000235:genetics / Q000503:physiopathology; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000188:drug therapy / Q000235:genetics / Q000503:physiopathology; D009124:Muscle Proteins / Q000235:genetics; D009154:Mutation
D047228:Angiotensin II Type 1 Receptor Blockers; D009124:Muscle Proteins; D000804:Angiotensin II